Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$245M |
| 2 |
Apple
AAPL
|
+$91.7M |
| 3 |
PENN Entertainment
PENN
|
+$47.4M |
| 4 |
Eversource Energy
ES
|
+$42.9M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coursera
COUR
|
+$25.2M |
| 2 |
Applovin
APP
|
+$22.4M |
| 3 |
Cognizant
CTSH
|
+$20.7M |
| 4 |
Corpay
CPAY
|
+$19.5M |
| 5 |
Akamai
AKAM
|
+$18.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.13% |
| 2 | Communication Services | 13.73% |
| 3 | Healthcare | 12.21% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Energy | 5.87% |
Similar funds
Invenomic Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Invenomic Capital Management held 169 positions worth $2.38B, up 21% from $1.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Invenomic Capital Management deployed $540M of net new capital in Q3 2023, opening 35 new positions and adding to 72 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was Applovin, an estimated $22.4M trimmed.
- Invenomic Capital Management's largest Q3 2023 buy was State Street SPDR S&P 500 ETF Trust: 550,000 shares worth $235M.
- Invenomic Capital Management added most to Citigroup in Q3 2023, an estimated $37.9M increase.
- Invenomic Capital Management's biggest Q3 2023 reduction was Applovin, cutting an estimated $22.4M.
- Invenomic Capital Management fully exited Coursera in Q3 2023, selling an estimated $25.2M.
- Invenomic Capital Management's ten largest holdings make up 32% of its $2.38B portfolio in Q3 2023.
- Invenomic Capital Management opened 35 new positions and closed 24 in Q3 2023.
- Invenomic Capital Management's portfolio value rose 21% quarter-over-quarter to $2.38B.
Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.